ATE216723T1 - Hormones de croissance humaines mutantes et leur utilisation - Google Patents

Hormones de croissance humaines mutantes et leur utilisation

Info

Publication number
ATE216723T1
ATE216723T1 AT97300902T AT97300902T ATE216723T1 AT E216723 T1 ATE216723 T1 AT E216723T1 AT 97300902 T AT97300902 T AT 97300902T AT 97300902 T AT97300902 T AT 97300902T AT E216723 T1 ATE216723 T1 AT E216723T1
Authority
AT
Austria
Prior art keywords
growth hormone
mutantes
humanes
croissance
hormones
Prior art date
Application number
AT97300902T
Other languages
English (en)
Inventor
Kazuo Chihara
Original Assignee
Japan Chem Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26391431&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE216723(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Japan Chem Res filed Critical Japan Chem Res
Application granted granted Critical
Publication of ATE216723T1 publication Critical patent/ATE216723T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
AT97300902T 1996-02-13 1997-02-12 Hormones de croissance humaines mutantes et leur utilisation ATE216723T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5094096 1996-02-13
JP17864396 1996-06-18

Publications (1)

Publication Number Publication Date
ATE216723T1 true ATE216723T1 (de) 2002-05-15

Family

ID=26391431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97300902T ATE216723T1 (de) 1996-02-13 1997-02-12 Hormones de croissance humaines mutantes et leur utilisation

Country Status (8)

Country Link
US (1) US6238915B1 (de)
EP (1) EP0790305B1 (de)
KR (1) KR980002066A (de)
AT (1) ATE216723T1 (de)
AU (1) AU723494B2 (de)
BR (1) BR9700957A (de)
CA (1) CA2197408A1 (de)
DE (1) DE69712124T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780613B1 (en) 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
EP0397834B1 (de) 1988-10-28 2000-02-02 Genentech, Inc. Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
JP3417558B2 (ja) 1991-05-10 2003-06-16 ジェネンテク，インコーポレイテッド 配位子作用薬および拮抗薬の選択
US6506595B2 (en) * 1998-03-31 2003-01-14 Itoham Foods Inc. DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs
IL152706A0 (en) * 2000-05-12 2003-06-24 Univ Wales Medicine Method for detecting growth hormone variations in humans, the variations and their uses
GB0011459D0 (en) * 2000-05-12 2000-06-28 Univ Wales Medicine Sequences
BR0214017A (pt) * 2001-11-09 2005-01-04 Upjohn Co Polimorfismos de um único nucleotìdeo em gh-1
GB0127213D0 (en) * 2001-11-12 2002-01-02 Univ Wales Medicine Method of detecting growth hormone variations in humans the variations and their uses
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
GB0229725D0 (en) * 2002-12-19 2003-01-29 Univ Wales Medicine Haplotype partitioning and growth hormone SNPs
SE0300959D0 (sv) * 2002-12-19 2003-04-02 Pharmacia Ab Methods for predicting therapeutic response to agents acting on the growth hormone receptor
NZ525314A (en) * 2002-12-19 2005-02-25 Univ Cardiff Method and kit for diagnosing growth hormone dysfunction by determining SNP haplotypes of the proximal promoter region of the gene GH1
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP2446898A1 (de) 2010-09-30 2012-05-02 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Wachstumshormonen zur Verbesserung der Immunantwort bei immunsupprimierten Patienten
EP3820497A4 (de) * 2018-07-11 2022-03-23 Ohio University Inhibitoren der wachstumshormonwirkung auf peptid-basis und verfahren zu deren verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG49718A3 (bg) 1983-07-15 1992-01-15 Bio- Technology General Corp Метод за получаване на полипептид със супероксиддисмутазна активност
US5534617A (en) * 1988-10-28 1996-07-09 Genentech, Inc. Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
EP0397834B1 (de) * 1988-10-28 2000-02-02 Genentech, Inc. Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
WO1992019736A1 (en) * 1991-05-01 1992-11-12 Ohio University Growth hormone antagonists

Also Published As

Publication number Publication date
EP0790305B1 (de) 2002-04-24
CA2197408A1 (en) 1997-08-14
EP0790305A1 (de) 1997-08-20
US6238915B1 (en) 2001-05-29
BR9700957A (pt) 1998-12-08
DE69712124D1 (de) 2002-05-29
AU1266497A (en) 1997-08-21
AU723494B2 (en) 2000-08-31
KR980002066A (ko) 1998-03-30
DE69712124T2 (de) 2002-12-12

Similar Documents

Publication Publication Date Title
DE69712124D1 (de) Hormones de croissance humaines mutantes et leur utilisation
DE69021263D1 (de) Fibronektinbindungsprotein und dessen Herstellung.
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
DE69101217D1 (de) Ski mit laufflächenteil, ober Körper und Support für Bindungen.
EP0849361A3 (de) Neue Liganden des Neuropeptide Rezeptors HFGAN72
WO2000066730A3 (en) Laminin 2 and methods for its use
DE3466879D1 (en) Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
HUP9902640A2 (hu) Gliasejtvonal-eredetű neurotróf faktor receptor
ATE346083T1 (de) Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
ATE120494T1 (de) Fibronectinbindungsprotein und dessen herstellung.
GB8821785D0 (en) Peptide compounds
ES2192199T3 (es) Ligandos de la familia eph biologicamente activos.
FI863626A7 (fi) DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä.
DE69028783D1 (de) Künstliche peptide, die die zellbindung steigern
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DK0977859T3 (da) Den neurotrofiske faktor NNT-1
EP0676413A3 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung.
FI962044A7 (fi) DNA-sekvenssejä, jotka koodittavat sian haiman karboksipeptidaasi-B:tä
EP0320207A3 (de) Methoden und Zusammensetzungen zur Aktivierung der menschlichen Insulinrezeptorkinase
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
DE69637624D1 (de) Faktor-2 homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung
WO2001029084A3 (en) Novel human proteins and polynucleotides encoding the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties